Literature DB >> 9326301

L-DOPA is a substrate for tyrosine hydroxylase.

J Haavik1.   

Abstract

In the presence of thiols, tyrosine hydroxylase (TH) oxidizes L-dihydroxyphenylalanine (L-DOPA) with a specific activity of up to 140 nmol min(-1) mg(-1) at 37 degrees C and pH 7.0, which is approximately 12-50% of its TH activity under similar experimental conditions. Using assay conditions that are optimal for measuring TH activity, the specific DOPA oxidase activity of human TH is similar to that of mushroom tyrosinase, but the two enzymes are clearly different in terms of substrate specificities, cofactor dependencies, and selectivity with respect to the effects of metal chelators and other inhibitors. In the presence of an excess of dithiothreitol, 2-mercaptoethanol, cysteine, or reduced glutathione, the reaction products of the two enzymes are identical and have been identified tentatively as thioether derivatives of DOPA. Theoretically, the oxidation of L-DOPA by TH may contribute to the formation of neuromelanin (pheomelanin) in catecholaminergic neurons and in the metabolism of DOPA to reactive intermediates that can react with free thiol groups in cellular proteins. The DOPA oxidase activity of TH can lead to errors in the estimation of in vivo or in vitro TH activity, and currently used assay protocols may have to be modified to avoid interference from this activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326301     DOI: 10.1046/j.1471-4159.1997.69041720.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  12 in total

Review 1.  Subcellular proteomics reveals neuromelanin granules to be a lysosome-related organelle.

Authors:  F Tribl; K Marcus; H E Meyer; G Bringmann; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

Review 2.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

Review 3.  Hypoxia inducible factor-1 as a target for neurodegenerative diseases.

Authors:  Z Zhang; J Yan; Y Chang; S ShiDu Yan; H Shi
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 4.  Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?

Authors:  M G Murer; R Raisman-Vozari; O Gershanik
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

5.  Neurotoxicity due to o-quinones: neuromelanin formation and possible mechanisms for o-quinone detoxification.

Authors:  F Solano; V J Hearing; J C García-Borrón
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

6.  Intraneuronal dopamine-quinone synthesis: a review.

Authors:  D Sulzer; L Zecca
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

Review 7.  Tyrosine hydroxylase and Parkinson's disease.

Authors:  J Haavik; K Toska
Journal:  Mol Neurobiol       Date:  1998-06       Impact factor: 5.590

Review 8.  Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.

Authors:  Shengli Xu; Piu Chan
Journal:  Biomolecules       Date:  2015-06-05

9.  Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia.

Authors:  Agnete Fossbakk; Rune Kleppe; Per M Knappskog; Aurora Martinez; Jan Haavik
Journal:  Hum Mutat       Date:  2014-06-03       Impact factor: 4.878

10.  Therapeutic Potential of a Prolyl Hydroxylase Inhibitor FG-4592 for Parkinson's Diseases in Vitro and in Vivo: Regulation of Redox Biology and Mitochondrial Function.

Authors:  Xuan Li; Xin-Xin Cui; Ya-Jing Chen; Ting-Ting Wu; Huaxi Xu; Huiyong Yin; Yun-Cheng Wu
Journal:  Front Aging Neurosci       Date:  2018-04-27       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.